AAV9: a potential blood-brain barrier buster
Authors:
Open Access
- 1 March 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (3) , 403-405
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- Neonatal Intraperitoneal or Intravenous Injections of Recombinant Adeno-Associated Virus Type 8 Transduce Dorsal Root Ganglia and Lower Motor NeuronsHuman Gene Therapy, 2008
- Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2007
- Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy VectorJournal of Virology, 2007
- Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2006
- Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein MiceJournal of Neuroscience, 2006
- Single Amino Acid Changes Can Influence Titer, Heparin Binding, and Tissue Tropism in Different Adeno-Associated Virus SerotypesJournal of Virology, 2006
- α2,3 and α2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6Journal of Virology, 2006
- Adeno-Associated Virus Type 2 Contains an Integrin α5β1 Binding Domain Essential for Viral Cell EntryJournal of Virology, 2006
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004